The initial report of RTOG 0436: A phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for patients with esophageal cancer treated without surgery.
Mohan Suntharalingam
No relevant relationships to disclose
Kathryn Winter
No relevant relationships to disclose
David H. Ilson
No relevant relationships to disclose
Adam Dicker
No relevant relationships to disclose
Lisa A. Kachnic
No relevant relationships to disclose
Andre A. Konski
No relevant relationships to disclose
Bapsi Chakravarthy
No relevant relationships to disclose
David K. Gaffney
No relevant relationships to disclose
Harish V. Thakrar
No relevant relationships to disclose
Margit Naomi Horiba
No relevant relationships to disclose
Melvin Deutsch
No relevant relationships to disclose
Vivek Kavadi
No relevant relationships to disclose
Adam Raben
No relevant relationships to disclose
Kevin S. Roof
No relevant relationships to disclose
Gregory M. M. Videtic
No relevant relationships to disclose
Jondavid Pollock
No relevant relationships to disclose
Howard Safran
Disclosure not yet available
Christopher H. Crane
No relevant relationships to disclose